MX9605830A - Inhibicion de la infeccion de las celulas de mamiferos por el virus sincicial respiratorio. - Google Patents

Inhibicion de la infeccion de las celulas de mamiferos por el virus sincicial respiratorio.

Info

Publication number
MX9605830A
MX9605830A MX9605830A MX9605830A MX9605830A MX 9605830 A MX9605830 A MX 9605830A MX 9605830 A MX9605830 A MX 9605830A MX 9605830 A MX9605830 A MX 9605830A MX 9605830 A MX9605830 A MX 9605830A
Authority
MX
Mexico
Prior art keywords
infection
casein
beta
mammalian cells
human
Prior art date
Application number
MX9605830A
Other languages
English (en)
Other versions
MXPA96005830A (es
Inventor
Pradip Mukerji
Amanda Eun-Yeong Seo
Steven Neal Anderson
Joseph Paul Schaller
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/249,554 external-priority patent/US5506209A/en
Priority claimed from US08/249,555 external-priority patent/US5538952A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9605830A publication Critical patent/MX9605830A/es
Publication of MXPA96005830A publication Critical patent/MXPA96005830A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La infeccion de las células de mamíferos por virus sincicial respiratorio se puede inhibir mediante la B-caseína humana activa, una forma recombinante de la B-caseína contenida en la leche humana e hidrolisatos de ambas. La B-caseína humana o el hidrolisato puede estar contenido en un producto nutritivo enteral líquido tal como una formula para lactantes. El producto nutritivo se puede usar, por ejemplo para la prevencion y el tratamiento de la infeccion del tracto respiratorio en lactantes. La B-caseína humana o el hidrolisato se puede administrar también como un pulverizador para la garganta o nasalmente usando gotas o un pulverizador.
MXPA/A/1996/005830A 1994-05-26 1995-03-27 Inhibicion de la infeccion de las celulas demamiferos por el virus sincicial respiratorio MXPA96005830A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/249,554 US5506209A (en) 1994-05-26 1994-05-26 Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US08/249,555 US5538952A (en) 1994-05-26 1994-05-26 Inhibition of infection of mammalian cells by respiratory syncytial virus
US08249554 1994-05-26
US08249555 1994-05-26

Publications (2)

Publication Number Publication Date
MX9605830A true MX9605830A (es) 1998-06-30
MXPA96005830A MXPA96005830A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
CA2190609A1 (en) 1995-12-07
NZ283578A (en) 1998-05-27
AU697616B2 (en) 1998-10-15
WO1995032727A1 (en) 1995-12-07
JPH10500100A (ja) 1998-01-06
AU2192095A (en) 1995-12-21
EP0760674A1 (en) 1997-03-12

Similar Documents

Publication Publication Date Title
ZA888461B (en) Azelastine-containing medicaments for application in the nose and/or at the eye
HU912064D0 (en) Process for the production of aralyphic n-substituted amino-alcane-phosphine acids and medical preparations containing them
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
EP0660705A4 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE.
GB9423695D0 (en) Purified forms of dnase
PT914110E (pt) Metodo de modulacao da micro-circulacao
IL108625A (en) 2-(4-bicyclichetero- arylmethylphenyl)- cyclohexane-1- carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
AU7405091A (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
PH27446A (en) Compound with gastric acid inhibitory effect
MX9605830A (es) Inhibicion de la infeccion de las celulas de mamiferos por el virus sincicial respiratorio.
MX9803565A (es) Metodo para inhibir la union de h, influenzae a celulas humanas utilizando beta-caseina humana, fosforilada, recombinante.
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.
NZ329311A (en) use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus
IL102774A0 (en) Process for the preparation of human protein-containing,readily compatible medicaments for infusion or injection purposes
PT82847A (de) "4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaure-(n-(3-trifluormethyl-phenyl)-amide)zur antithrombotischen prophylaxe und behanbdlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln
EP0613375A4 (en) PHARMACEUTICAL LYSINE CONTAINING POLYPEPTIDE COMPOSITIONS AND METHOD FOR USE THEREOF.
MX9803568A (es) Producto para inhibir la union de h. influenzae a celulas humanas.
JPS649938A (en) Oral ingestive composition
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
ATE74354T1 (de) N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees